BioCryst's Ebola Candidate Moving to Efficacy Study Soon - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 2:08PM CDT
BioCryst 's (BCRX) BCX4430 will be evaluated in a non-human primate study shortly.
Glaxo Up on Accelerated Ebola Vaccine Development Process - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 1:50PM CDT
Glaxo's Ebola vaccine development process has been fast-tracked by an international consortium.
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK
PR Newswire - Tue Sep 02, 8:00AM CDT
Today, Analysts Review released its research reports regarding WellPoint Inc. (NYSE: WLP), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), Zoetis Inc. (NYSE: ZTS), Sanofi SA (NYSE: SNY) and GlaxoSmithKline plc (NYSE: GSK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6142-100free.
Nasdaq stocks posting largest percentage increases
AP - Fri Aug 29, 12:19PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
'Fast Money' Recap: When Is the Next Market Correction?
at The Street - Fri Aug 29, 4:00AM CDT
The trading panel discussed when the market will pull back, cyber attacks and the company making Apple's sapphire screens.
Why Tekmira Pharmaceuticals (TKMR) Stock Is Surging Today
at The Street - Thu Aug 28, 10:12AM CDT
Tekmira Pharmaceuticals (TKMR) surged Thursday as takeover talks swirl around the Vancouver-based biotech company.
Why Tekmira Pharmaceuticals (TKMR) Stock Is Gaining Today
at The Street - Thu Aug 21, 9:30AM CDT
Monkeys sickened by Marburg virus, an Ebola relative that kills in the same way and is equally as fatal, survived the disease after being treated with its experimental drug.
Tekmira Pharmaceuticals (TKMR) Is Today's Dead Cat Bounce Stock
at The Street - Thu Aug 21, 8:45AM CDT
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "dead cat bounce" (down big yesterday but up big today) candidate
The Zacks Analyst Blog Highlights: Johnson & Johnson, Tekmira Pharmaceuticals, GileadSciences, Allergan and Supernus Pharmaceuticals
PR Newswire - Thu Aug 21, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Johnson & Johnson (NYSE:JNJ-Free Report), Tekmira Pharmaceuticals Corp (Nasdaq:TKMR-Free Report), Gilead Sciences Inc. (Nasdaq:GILD-Free Report), Allergan Inc. (NYSE:AGN-Free Report) and Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN-Free Report).
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 20, 3:27PM CDT
Favorable industry trends in the pharma and bio-tech space makes the healthcare sector a lucrative investment destination.
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication
GlobeNewswire - Wed Aug 20, 1:00PM CDT
Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced the publication of data in a peer-reviewed scientific journal which highlights positive results in an animal model of Marburg virus infection enabled by Tekmira's lipid nanoparticle (LNP) technology.
5 Stocks Jumping on Unusual Volume
at The Street - Tue Aug 19, 5:30AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Why Tekmira Pharmaceuticals (TKMR) Stock Is Spiking Today
at The Street - Mon Aug 18, 12:29PM CDT
Tekmira Pharmaceuticals (TKMR) shares are up double digits after having coverage initiated with an 'outperform' rating and $25 price target by analysts at Leerink.
NewLink Genetics: Ready to test Ebola vaccine
By TOM MURPHY - AP - Thu Aug 14, 3:25PM CDT
An Iowa drug developer is preparing to test a possible Ebola vaccine in humans, as scientists race to develop ways to prevent or fight a virus that has killed more than 1,000 people in a West African outbreak.
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna
PR Newswire - Thu Aug 14, 7:30AM CDT
Today, Analysts Review released its research reports regarding Tekmira Pharmaceuticals Corp. (NASDAQ: TKMR), MannKind Corp. (NASDAQ: MNKD), Eli Lilly and Company (NYSE: LLY), GlaxoSmithKline PLC (NYSE: GSK) and Cigna Corp. (NYSE: CI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5727-100free.